*Disclaimer

BCAL DIAGNOSTICS LIMITED (ASX: BDX)

🔗 📄 📈

BDX: Quarterly Activities/Appendix 4C Cash Flow Report

BCAL DIAGNOSTICS LIMITED

  1. BCAL Diagnostics Limited is developing a blood-based test for detection of breast cancer in its early stages.
  2. The test has consistently shown high sensitivity and specificity in identifying patients.
  3. BCAL has established a development and clinical service laboratory in Sydney to accelerate market access for the BCAL Dx test.

2023-01-16 09:07:00